Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, směrnice pro lékařskou praxi
PubMed
28453614
DOI
10.1093/annonc/mdx096
PII: S0923-7534(19)42145-5
Knihovny.cz E-zdroje
- MeSH
- hodnocení rizik MeSH
- lékařská onkologie normy MeSH
- lidé MeSH
- mnohočetný myelom diagnóza patologie terapie MeSH
- následné studie MeSH
- staging nádorů MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- směrnice pro lékařskou praxi MeSH
Clinica Universidad de Navarra CIMA IDISNA Pamplona Spain
Department of Clinical Therapeutics School of Medicine University of Athens Athens Greece
Department of Hematology VU University Medical Center Amsterdam The Netherlands
Department of Internal Medicine 2 University Hospital Wuerzburg Wuerzburg Germany
Department of Medicine University of Heidelberg Heidelberg
Erasmus Medical Center Institute Rotterdam The Netherlands
Faculty of Medicine University Hospital Ostrava Ostrava Czech Republic
Haematology Department University Hospital Hôtel Dieu Nantes France
Seragnoli Institute of Hematology School of Medicine Bologna University Bologna Italy
The Cancer Research Center of Toulouse CRCT INSERM U 1037 Toulouse France
University Hospital Huriez Lille France
University Hospital of Salamanca IBSAL Salamanca Spain
Wilhelminen Cancer Research Institute Wilhelminenspital Vienna Austria
Citace poskytuje Crossref.org
Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
Melflufen: A Peptide-Drug Conjugate for the Treatment of Multiple Myeloma
Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma
Insights on Multiple Myeloma Treatment Strategies
